XOMA Royalty (XOMA) EPS (Diluted) Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) EPS (Diluted) Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.04% |
| Dec 31, 2025 | -23.74% |
| Jun 30, 2025 | -13.90% |
| Mar 31, 2025 | 17.85% |
| Dec 31, 2024 | -10.62% |
| Sep 30, 2024 | -44.84% |
| Jun 30, 2024 | -29.03% |
| Mar 31, 2024 | -385.15% |
| Dec 31, 2023 | -447.76% |
| Sep 30, 2023 | -357.74% |
| Jun 30, 2023 | -479.10% |
| Mar 31, 2023 | -362.20% |
| Dec 31, 2022 | -27.14% |
| Sep 30, 2022 | -19.16% |
| Jun 30, 2022 | -119.43% |
| Mar 31, 2022 | 41.44% |
| Dec 31, 2021 | 23.25% |
| Sep 30, 2021 | 28.35% |
| Jun 30, 2021 | 42.52% |
| Mar 31, 2021 | 14.31% |